Amevive Wisdom Acquired Through Real-World Evidence - 2 (A.W.A.R.E.-2) Program: Long-Term Study.

Trial Profile

Amevive Wisdom Acquired Through Real-World Evidence - 2 (A.W.A.R.E.-2) Program: Long-Term Study.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2013

At a glance

  • Drugs Alefacept (Primary)
  • Indications Plaque psoriasis
  • Focus Adverse reactions; Biomarker; Therapeutic Use
  • Acronyms AWARE-2
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 09 Mar 2011 Planned end date changed from 1 Mar 2011 to 1 Jan 2011 as reported by ClinicalTrials.gov.
    • 09 Mar 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 29 Oct 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top